Icon International, Inc. v. Elevation Health LLC

CourtDistrict Court, S.D. New York
DecidedSeptember 6, 2024
Docket1:22-cv-04304
StatusUnknown

This text of Icon International, Inc. v. Elevation Health LLC (Icon International, Inc. v. Elevation Health LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Icon International, Inc. v. Elevation Health LLC, (S.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ---------------------------------------------------------------X ICON INTERNATIONAL, INC., : Plaintiff, OPINION AND ORDER : 22 Civ. 4304 (MKV) (GWG) -against- :

ELEVATION HEALTH LLC, :

Defendant. : ---------------------------------------------------------------X GABRIEL W. GORENSTEIN, United States Magistrate Judge Plaintiff Icon International, Inc. (“Icon”) brought this action against defendant Elevation Health LLC (“Elevation”) for breach of contract. See Complaint and Jury Demand, filed May 25, 2022 (Docket # 1) (“Compl.”). Elevation then filed counterclaims against Icon and third- party claims against third-party defendants Gypset, Inc. (“Gypset”), Dayna Robin-Zegarelli, Joe Davis, Clarence V. Lee, III, Mario Gonzalez, and Khalid Itum. See Amended Counterclaim, filed Dec. 8, 2022 (Docket # 38) (“Amended Counterclaim”); Amended Third-Party Complaint, filed December 8, 2022 (Docket # 39) (“Amended Third-Party Complaint”).1 Icon and the third- party defendants (collectively, “Icon Parties”) failed to fulfill their discovery obligations. Before the Court is Elevation’s motion for sanctions related to those failures.2 For the following reasons, Elevation’s motion is granted in part and denied in part.

1 The allegations in the Amended Counterclaim and the Amended Third-Party Complaint are identical. For simplicity, we cite only to the Amended Counterclaim.

2 See Notice of Motion for Sanctions, filed Mar. 13, 2024 (Docket # 111) (“Mot.”); Declaration of Ran Mukherjee, filed Mar. 13, 2024 (Docket # 114) (“Mukherjee Decl.”); Memorandum of Law in Support, filed Mar. 13, 2024 (Docket # 116) (“Mem.”); Memorandum of Law in Opposition, filed Apr. 29, 2024 (Docket # 126) (“Icon Opp.”); Declaration of Clarence V. Lee III, filed Apr. 29, 2024 (Docket # 127) (“Lee Decl.”); Declaration of Ryan Crosby, filed Apr. 29, 2024 (Docket # 128) (“Crosby Decl.”); Declaration of Greg Caglione, filed Apr. 29, 2024 (Docket # 129) (“Caglione Decl.”); Declaration of Dayna Robin-Zegarelli, filed Apr. 29, I. BACKGROUND Icon filed this case on May 25, 2022, seeking to collect payment from Elevation for a shipment of iHealth COVID-19 test kits it had allegedly delivered. See Compl. On July 13, 2022, Elevation answered the complaint and brought a counterclaim against Icon and a third-

party claim against Gypset. See Answer, Counterclaim and Third Party Complaint, filed July 13, 2022 (Docket # 11). On December 5, 2022, the district court granted Elevation’s motion to amend its answer, which resulted in Elevation filing the operative pleadings in this case: the Amended Counterclaim and the Amended Third-Party Complaint. See Order, filed Dec. 5, 2022 (Docket # 35). The amended pleadings brought several individuals, Robin-Zegarelli, Davis, Lee, Gonzalez, and Itum, into the action as third-party defendants. See Amended Counterclaim; Amended Third-Party Complaint. Because the instant motion relates to Elevations’ efforts to obtain evidence to support its case, we summarize Elevation’s allegations. The allegations in the counterclaim give a history of the interaction between Elevation,

through one of its members, Joseph Goldsmith, and various individuals who were either associated with Icon or Gypset. See Amended Counterclaim ¶¶ 16-98. Elevation alleges that there was an agreement between Icon and Gypset that “in exchange for money paid to Gypset via Zegarelli, Lee would cause ICON to deliver Test Kits (the ‘Agreement’).” Id. ¶ 39. Elevation

2024 (Docket # 130) (“Robin-Zegarelli Decl.”); Declaration of Joey Davis, filed Apr. 29, 2024 (Docket # 131) (“Davis Decl.”); Declaration of Scott T. Tross, Esq., filed Apr. 29, 2024 (Docket # 132) (“Tross Decl.”); Letter, filed May 3, 2024 (Docket # 133) (“Gonzalez Opp.”); Declaration of Siddartha Rao, filed May 6, 2024 (Docket # 134) (“Rao Decl.”); Memorandum of Law in Opposition, filed May 6, 2024 (Docket # 135) (“Itum Opp.”); Reply Memorandum of Law, filed May 13, 2024 (Docket # 136) (“Reply”); Declaration of Ran Mukherjee, filed May 13, 2024 (Docket # 137) (“Mukherjee Reply Decl.”). alleges that “Gonzales [sic], Itum, and Davis were part of the Agreement, and/or helped to broker it, and in any event expected to profit from it and did in fact profit from it.” Id. ¶ 40. Elevation alleges that Lee directed Robin-Zegarelli to send a letter to Elevation representing that it had possession of test kits, even though Lee knew this to be false and knew

that Icon and Gypset were not legally authorized to distribute the test kits. Id. ¶ 43. Elevation alleges that “[t]he Emergency Use Authorization (‘EUA’) granted by the U.S. Food and Drug Administration (‘FDA’) on December 22, 2021,” permitted test kits “to be sold in interstate commerce in the United States” only by “authorized distributors.” Id. ¶ 88. Elevation attaches a December 31, 2021 letter to the Amended Counterclaim that appears on Gypset letterhead. See Letter, annexed as Ex. 1 to Amended Counterclaim (Docket # 38-1). The letter states that Gypset understood all the “USG requirements” for distribution test kits (presumably referring to the United States government), would “meet and exceed” all such requirements, and was ready and able to fully deliver 1,504,200 iHealth test kits by January 5, 2022, if it received a “wire” payment of an unspecified amount. Id. This letter is alleged to have

been sent pursuant to Gypset’s “joint venture” with Icon. Amended Counterclaim ¶ 44. On December 31, 2021, in reliance on this and other communications, Elevation wired $2,640,000 to the account specified. Id. ¶¶ 49-51. The invoice Elevation received represented that 400,000 test kits could be shipped within 24 hours of the receipt of the wire. Id. ¶ 48. Despite multiple promises of earlier shipments, including photographs of test kits that were allegedly being shipped, the test kits were not shipped until the second half of February 2022. Id. ¶ 52-79, 87. In the meantime, Elevation’s multiple requests for refunds were ignored. Id. ¶¶ 60, 64, 66, 68, 77. Elevation alleges that the Icon Parties’ assertions that they had possession of the test kits or that they were available for shipping were false because the Icon Parties did not have possession of the test kits and, because none of the parties were “authorized distributors,” they were not legally authorized to sell or distribute the test kits. Id. ¶¶ 80-83. Elevation alleges that

Icon’s authorized distributor status was received at the earliest on or about February 1, 2022, and was revoked by iHealth in or around June 2022. Id. ¶ 94. It is alleged that Gypset was never an authorized distributor. Id. ¶ 95. Elevation also alleges that government regulations and “custom and practice in the industry” require that there be “proper documentation of the chain of custody” to ensure compliance with those regulations. Id. ¶¶ 90-91. But the test kits arrived “without the proper chain of custody documentation or lot numbers that should have demonstrated that the Test Kits were legitimate, and originated properly from iHealth, as opposed to being counterfeit Test Kits.” Id. ¶ 92. Elevation never sold the test kits and Icon and Gypset have refused to take them back or

refund Elevation’s money. Id. ¶¶ 97-98. II. PROGRESS OF DISCOVERY The initial scheduling order in this case required that fact discovery be completed by January 13, 2023. See Civil Case Management Plan and Scheduling Order, filed Sept. 20, 2022 (Docket # 18), at 2. During the course of this case, the Icon Parties never served any discovery requests of their own. See Icon Opp. at 10. Elevation did so, however, and on October 24, 2022, Icon responded to Elevation’s first set of document requests and interrogatories. See Plaintiff’s Responses and Objects to Defendant’s First Set of Interrogatories, annexed as Ex. A to Mukherjee Decl.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Link v. Wabash Railroad
370 U.S. 626 (Supreme Court, 1962)
Gallop v. Cheney
660 F.3d 580 (Second Circuit, 2011)
Richard DeLauro v. Ralph F. Porto
645 F.3d 1294 (Eleventh Circuit, 2011)
Salahuddin v. Harris
782 F.2d 1127 (Second Circuit, 1986)
William C. Shea v. Donohoe Construction Co., Inc
795 F.2d 1071 (D.C. Circuit, 1986)
Patterson v. Balsamico
440 F.3d 104 (Second Circuit, 2006)
Design Strategy, Inc. v. Davis
469 F.3d 284 (Second Circuit, 2006)
Shcherbakovskiy v. Da Capo Al Fine, Ltd.
490 F.3d 130 (Second Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Icon International, Inc. v. Elevation Health LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/icon-international-inc-v-elevation-health-llc-nysd-2024.